loratadine has been researched along with prednisolone in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Henz, BM; Iffländer, J; Semmler, C; Zuberbier, T | 1 |
| Dawn, G; Francis, DM; Gibbs, S; Grattan, CE | 1 |
| Kavoliūniene, A; Petrauskiene, I; Satkiene, D; Sirvyte, R | 1 |
| Bonanni, L; Parmiani, S; Sturbini, S | 1 |
| Cherian, M; Chew, GY; Hawkins, CA; Hurwitz, M | 1 |
| deRossi, T; Hagel, A; Hahn, EG; Konturek, P; Kressel, J; Nägel, A; Raithel, M; Stengel, Ch; Zopf, Y | 1 |
| Eigelshoven, S; Homey, B; Korkmaz, H | 1 |
| Choi, JS; Kim, M; Li, C | 1 |
| Meijer, JM; van Dalen, T; van der Wal, B | 1 |
1 review(s) available for loratadine and prednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for loratadine and prednisolone
| Article | Year |
|---|---|
Acute urticaria: clinical aspects and therapeutic responsiveness.
Topics: Acute Disease; Adolescent; Adult; Analgesics; Anti-Inflammatory Agents; Child; Child, Preschool; Drug Eruptions; Female; Follow-Up Studies; Food Hypersensitivity; Histamine H1 Antagonists; Humans; Immunoglobulin E; Loratadine; Male; Middle Aged; Prednisolone; Prospective Studies; Remission Induction; Respiratory Tract Infections; Time Factors; Treatment Outcome; Urticaria | 1996 |
[Chronic inflammatory bowel diseases. Do antihistaminics reduce the need for steroids?].
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Loratadine; Mesalamine; Prednisolone | 2000 |
Plasma histamine levels (H) during adjunctive H1-receptor antagonist treatment with loratadine in patients with active inflammatory bowel disease (IBD).
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Histamine; Histamine H1 Antagonists; Humans; Inflammatory Bowel Diseases; Loratadine; Mesalamine; Prednisolone | 2010 |
11 other study(ies) available for loratadine and prednisolone
| Article | Year |
|---|---|
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity.
Topics: Adult; Analysis of Variance; Anti-Inflammatory Agents; Basophils; Case-Control Studies; Chronic Disease; Circadian Rhythm; Female; Histamine H1 Antagonists, Non-Sedating; Histamine Release; Humans; Leukocyte Count; Leukopenia; Loratadine; Male; Middle Aged; Prednisolone; Skin; Urticaria | 2003 |
[Tongue angioedema associated with angiotensin-converting enzyme inhibitor (diagnosis, differential diagnosis, treatment)].
Topics: Algorithms; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Antihypertensive Agents; Diagnosis, Differential; Diphenhydramine; Drug Therapy, Combination; Glossitis; Histamine H1 Antagonists, Non-Sedating; Humans; Hypnotics and Sedatives; Loratadine; Male; Middle Aged; Prednisolone; Ramipril; Time Factors; Treatment Outcome | 2003 |
Glottis oedema due to loratadine.
Topics: Adult; Anti-Allergic Agents; Female; Follow-Up Studies; Humans; Laryngeal Edema; Loratadine; Prednisolone; Rare Diseases; Rhinitis, Allergic, Perennial; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2004 |
Roxithromycin induced hypersensitivity pneumonitis.
Topics: Alveolitis, Extrinsic Allergic; Anti-Allergic Agents; Anti-Bacterial Agents; Drug Eruptions; Drug Therapy, Combination; Female; Histamine H2 Antagonists; Humans; Loratadine; Middle Aged; Prednisolone; Ranitidine; Roxithromycin; Treatment Outcome | 2006 |
[Omalizumab for therapy-resistant chronic urticaria with angioedema].
Topics: Adult; Angioedema; Anti-Allergic Agents; Anti-Inflammatory Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Chronic Disease; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Histamine H1 Antagonists, Non-Sedating; Humans; Immunoglobulin E; Leukocytosis; Loratadine; Male; Omalizumab; Prednisolone | 2010 |
Effects of prednisolone on the pharmacokinetics of loratadine after oral and intravenous administration of loratadine in rats.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cell Line; Dose-Response Relationship, Drug; Drug Interactions; Half-Life; Histamine H1 Antagonists, Non-Sedating; Humans; Immunosuppressive Agents; Injections, Intravenous; Loratadine; Male; Metabolic Clearance Rate; Prednisolone; Rats; Rats, Sprague-Dawley | 2010 |
A Patient with Jaundice and Pruritus, Not the Usual Suspect?
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Glucocorticoids; Glutamyl Aminopeptidase; Hepatitis, Autoimmune; Histamine H1 Antagonists, Non-Sedating; Humans; Hyperbilirubinemia; Jaundice; Loratadine; Male; Prednisolone; Pruritus; Urticaria | 2019 |